Literature DB >> 8609524

Prolonged neurological sequelae after combination treatment with lithium and antipsychotic drugs.

J Mani, S V Tandel, P U Shah, D R Karnad.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8609524      PMCID: PMC1073870          DOI: 10.1136/jnnp.60.3.350

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  5 in total

1.  Adverse reactions in treatment with lithium carbonate and haloperidol.

Authors:  P C Baastrup; P Hollnagel; R Sorensen; M Schou
Journal:  JAMA       Date:  1976-12-06       Impact factor: 56.272

2.  Reversible lithium neurotoxicity at normal serum level may refer to intracranial pathology.

Authors:  C J Kemperman; J H Gerdes; J De Rooij; L M Vencken
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-05       Impact factor: 10.154

3.  Lithium carbonate, haloperidol, and irreversible brain damage.

Authors:  W J Cohen; N H Cohen
Journal:  JAMA       Date:  1974-12-02       Impact factor: 56.272

Review 4.  Lithium toxicity: a review of neurologic complications.

Authors:  M E Sansone; D K Ziegler
Journal:  Clin Neuropharmacol       Date:  1985       Impact factor: 1.592

5.  Persisting neurologic sequelae of lithium carbonate therapy.

Authors:  I M Donaldson; J Cuningham
Journal:  Arch Neurol       Date:  1983-11
  5 in total
  2 in total

1.  Delirium and extrapyramidal symptoms due to a lithium-olanzapine combination therapy: a case report.

Authors:  Cengiz Tuglu; Esin Erdogan; Ercan Abay
Journal:  J Korean Med Sci       Date:  2005-08       Impact factor: 2.153

Review 2.  Drug Interactions with Lithium: An Update.

Authors:  Patrick R Finley
Journal:  Clin Pharmacokinet       Date:  2016-08       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.